Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-greenlights-drugs-ms-and-spinal-muscular-atrophy-2026a1000d3y?src=rss
Author :
Publish date : 2026-04-24 13:54:00
Copyright for syndicated content belongs to the linked Source.
